Here's Why Zoetis (ZTS) is a Strong Value Stock

10:43am, Tuesday, 28'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Controversy over a key osteoarthritis pain treatment has sunk Zoetis' stock. Despite the setback, the company has a robust pipeline and solid growth prospects.
Confluence Wealth Services Inc. boosted its position in Zoetis Inc. (NYSE: ZTS) by 553.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).

Cwm LLC Reduces Holdings in Zoetis Inc. $ZTS

03:59am, Friday, 24'th Apr 2026
Cwm LLC decreased its position in shares of Zoetis Inc. (NYSE: ZTS) by 61.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fi
Idexx Laboratories, Inc. and Zoetis Inc. are dominant players in animal health, but IDXX outperforms due to superior capital efficiency and recurring revenue flywheel. ZTS trades at a much lower valua
Mirae Asset Global Investments Co. Ltd. raised its position in Zoetis Inc. (NYSE: ZTS) by 10.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities an

Zoetis Inc. $ZTS Shares Sold by Berkeley Inc

03:38am, Friday, 17'th Apr 2026
Berkeley Inc cut its stake in shares of Zoetis Inc. (NYSE: ZTS) by 61.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 20,295 shares of the company's stoc
Zoetis (ZTS) concluded the recent trading session at $119.04, signifying a -1.42% move from its prior day's close.
Zoetis has strong growth prospects and an attractive income program. BioNTech has a rich pipeline that could help jolt the stock as it makes clinical progress.
One of Wall Street's top firms just gave a thumbs-up to Zoetis (NYSE:ZTS) stock.

Zoetis Inc. $ZTS Stock Holdings Cut by Choreo LLC

04:28am, Wednesday, 15'th Apr 2026
Choreo LLC reduced its position in shares of Zoetis Inc. (NYSE: ZTS) by 30.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor own
Baillie Gifford and Co. purchased a new stake in Zoetis Inc. (NYSE: ZTS) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 150,845
The mean of analysts' price targets for Zoetis (ZTS) points to a 28.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Carnegie Investment Counsel lessened its stake in shares of Zoetis Inc. (NYSE: ZTS) by 10.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE